Wednesday, May 29, 2019

Epigenetic study provides new approaches to combination therapies for aggressive cancers

A recent study reveals how the interaction of the epigenetic protein BRD4 with the metabolic enzyme MTHFD1 controls gene expression and cell proliferation. The results of the study have now been published in the renowned journal Nature Genetics. They suggest novel approaches for the development of combination therapies for aggressive cancers.

from Top Health News -- ScienceDaily http://bit.ly/2YOyvfA

No comments:

Post a Comment

Claude Fable 5 AI finds a tiny formula that topples an 87-year-old math conjecture

A mathematician working at Anthropic says he used the AI model Claude Fable 5 to uncover a remarkably simple counterexample to the Jacobian ...